Editas Medicine Inc (EDIT)
5.67
+0.05
(+0.89%)
USD |
NASDAQ |
May 03, 16:00
5.67
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Cash and Short Term Investments (Quarterly): 323.11M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 323.11M |
| September 30, 2023 | 349.62M |
| June 30, 2023 | 431.97M |
| March 31, 2023 | 318.44M |
| December 31, 2022 | 344.27M |
| September 30, 2022 | 419.62M |
| June 30, 2022 | 452.56M |
| March 31, 2022 | 488.36M |
| December 31, 2021 | 499.84M |
| September 30, 2021 | 557.84M |
| June 30, 2021 | 610.55M |
| March 31, 2021 | 625.33M |
| December 31, 2020 | 402.11M |
| September 30, 2020 | 495.30M |
| June 30, 2020 | 598.72M |
| March 31, 2020 | 414.99M |
| December 31, 2019 | 457.14M |
| September 30, 2019 | 332.62M |
| Date | Value |
|---|---|
| June 30, 2019 | 317.93M |
| March 31, 2019 | 342.06M |
| December 31, 2018 | 368.96M |
| September 30, 2018 | 337.49M |
| June 30, 2018 | 344.08M |
| March 31, 2018 | 358.82M |
| December 31, 2017 | 329.14M |
| September 30, 2017 | 295.69M |
| June 30, 2017 | 324.80M |
| March 31, 2017 | 351.55M |
| December 31, 2016 | 185.32M |
| September 30, 2016 | 199.87M |
| June 30, 2016 | 217.65M |
| March 31, 2016 | 229.20M |
| December 31, 2015 | 143.18M |
| September 30, 2015 | 155.30M |
| December 31, 2014 | 10.62M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
317.93M
Minimum
Jun 2019
625.33M
Maximum
Mar 2021
444.23M
Average
431.97M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 11.22B |
| Bristol-Myers Squibb Co | 9.67B |
| Regeneron Pharmaceuticals Inc | 10.52B |
| Cabaletta Bio Inc | 241.25M |
| Moderna Inc | 8.523B |